Pharmacosmos A/s
Clinical trials sponsored by Pharmacosmos A/s, explained in plain language.
-
New IV iron therapy could help kids with anemia who Can't take pills
Disease control Recruiting nowThis study tests an intravenous (IV) iron medicine called ferric derisomaltose in children aged 0 to 18 with iron deficiency anemia. It is for kids who either have chronic kidney disease or cannot take or do not respond to oral iron. The goal is to see if the treatment safely rai…
Phase: PHASE3 • Sponsor: Pharmacosmos A/S • Aim: Disease control
Last updated May 26, 2026 10:08 UTC
-
New drug combo aims to extend life in tough lung cancer
Disease control Recruiting nowThis study tests if a drug called trilaciclib, given before chemotherapy, helps people with advanced small cell lung cancer live longer. About 302 participants will receive either trilaciclib or a placebo alongside their chemo. The goal is to see if the drug improves survival wit…
Phase: PHASE4 • Sponsor: Pharmacosmos A/S • Aim: Disease control
Last updated May 26, 2026 08:20 UTC
-
New Iron-Clearing drug could ease transfusion side effects
Disease control Recruiting nowThis study tests a drug called SP-420 in people with two blood disorders—beta thalassemia and low-risk myelodysplastic syndromes—who need regular blood transfusions. Transfusions can cause dangerous iron buildup in organs. The drug aims to safely remove that extra iron. About 90 …
Phase: PHASE2 • Sponsor: Pharmacosmos A/S • Aim: Disease control
Last updated May 20, 2026 11:54 UTC